Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dagmar Adámková Krákorová"'
Autor:
Jiří Šedo, Renata Koukalová, Zuzana Šimková, Dagmar Adámková Krákorová, Petr Szturz, Pavel Fabian
Publikováno v:
Klinicka onkologie.
BACKGROUND At present, lung cancer ranks among the most frequent malignant diseases. However, according to literature data, mesenchymal lung tumors are very rare, representing less than 0.5% of all malignant lung tumours. Epithelioid hemangioendothel
Autor:
Štěpán Tuček, Pavel Janíček, Dagmar Adámková Krákorová, Katerina Kubackova, Jana Prausová, Iva Staniczková Zambo, Ladislav Dušek, Tomáš Tomáš, Igor Kiss
Publikováno v:
Pathology & Oncology Research. 24:623-630
Ewing sarcoma (ES) is an exceptionally rare tumor in adults. Data regarding outcomes of adult patients with ES and experiences with age-adapted therapeutic strategies are very limited. The aim of this study was to evaluate prognostic factors and clin
Autor:
Igor Kiss, S Tuček, Ondrej Bilek, Regina Demlová, Jana Halámková, Jan Kristek, Tomas Kazda, Iva Staniczková Zambo, Dagmar Adámková Krákorová
Publikováno v:
Medicine
Rationale: The Ewing sarcoma family of malignant tumors is a group of tumors characterized by morphologically similar round-cell neoplasms and by the presence of a common chromosomal translocation; Ewing sarcoma family of tumors typically occur in ch
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(3)
Mesenchymal malignancies are relatively rare tumors with distinct behaviors that are usually surgically removal. However, it is sometimes impossible to perform such surgery according to standardized procedures. In particular, surgical removal of intr
Autor:
Ladislav Dušek, Jana Halámková, Jiri Tomasek, Zdenek Kala, Rostislav Vyzula, Vlastimil Válek, Dagmar Adámková Krákorová, Iveta Zimová, Ján Podhorec, Jiri Prasek, Igor Kiss, S Tuček
Publikováno v:
Journal of Clinical Oncology. 31:155-155
155 Background: The transarterial chemoembolization (TACE) and the radiofrequency ablation (RFA) are the keystones of interventional therapy of primary and secondary liver malignancies in oncology. A compromised liver function may be a relative contr